Cargando…
Prevention by Chitosan of Myelotoxicity, Gastrointestinal Toxicity and Immunocompetent Organic Toxicity Induced by 5‐Fluorouracil without Loss of Antitumor Activity in Mice
We examined the antitumor activity and side effects (myelotoxicity, immunocompetent organic toxicity and gastrointestinal toxicity) of combined treatment with the cancer chemotherapy drug 5‐fluorouracil (5‐FU) and dietary fiber chitosan in sarcoma 180‐bearing mice. 5‐FU (12.5 mg/kg×2/ day) plus chit...
Autores principales: | Kimura, Yoshiyuki, Okuda, Hiromichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926136/ https://www.ncbi.nlm.nih.gov/pubmed/10470290 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00813.x |
Ejemplares similares
-
Evaluation of Myelotoxicity in Dietary Restricted Rats
por: Miyata, Hiroto, et al.
Publicado: (2009) -
Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients
por: Arshad, Usman, et al.
Publicado: (2020) -
Study on fluorouracil–chitosan nanoparticle preparation and its antitumor effect
por: Chen, Gaimin, et al.
Publicado: (2016) -
Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans
por: Naren, Gerile, et al.
Publicado: (2022) -
The protective effects of silymarin nanoemulsion on 5-fluorouracil-induced gastrointestinal toxicity in rats
por: Safarpour, Soheila, et al.
Publicado: (2023)